Bayer AC, Sanmarco LM, Pellerin A, Masi G, et al. Therapeutic IgG- and IgM-specific proteases disarm the acetylcholine receptor autoantibodies that drive myasthenia gravis pathology. Proc Natl Acad Sci U S A 2025;122:e2505984122.
PMID: 41118207